Ian McLeod

Comptroller/Controller/Auditor at ANIKA THERAPEUTICS, INC.

Health Technology

Consumer Services

Profile

Ian McLeod is currently the Chief Accounting Officer & Vice President at Anika Therapeutics, Inc. He previously worked as a Controller at ABIOMED, Inc. from 2007 to 2017 and as a Corporate Controller at Idenix Pharmaceuticals LLC from 2004 to 2007.
Mr. McLeod has an undergraduate degree from the University of Western Ontario and an MBA from McMaster University.

Ian McLeod active positions

Companies	Position	Start
ANIKA THERAPEUTICS, INC.	Comptroller/Controller/Auditor	2021-06-30

All active positions of Ian McLeod

Former positions of Ian McLeod

Companies	Position	End
IDENIX PHARMACEUTICALS INC	Comptroller/Controller/Auditor	2007-10-31
ABIOMED, INC.	Comptroller/Controller/Auditor	-

See the detail of Ian McLeod's experience

Training of Ian McLeod

University of Western Ontario	Undergraduate Degree
McMaster University	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ian McLeod's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ANIKA THERAPEUTICS, INC.	Health Technology

Private companies	2
ABIOMED, Inc. ABIOMED, Inc. Medical SpecialtiesHealth Technology ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA.	Health Technology
Idenix Pharmaceuticals LLC Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA.	Health Technology